ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Impact of Type of Kidney (Living vs. Deceased) on Urinary Podocyte Excretion Rate in Renal Allografts.

    A. Naik, D. Luan, D. Cibrik, M. Samaniego, K. Woodside, M. Chowdhury, S. Wang, R. Wiggins.

    U Michigan, Ann Arbor

    Aim: Long term allograft survival has not improved.Surveillance biopsy studies have demonstrated that chronic microcirculatory injury and progressive glomerulosclerosis are the most common histological finding…
  • 2017 American Transplant Congress

    A Thirteen-Year Mayo Clinic Retrospective Study of the Syndrome of Rapid Onset ESRD Among Renal Transplant Recipients, 2001-2013.

    M. Onuigbo,1,2 N. Agbasi.3

    1Medicine, Mayo Clinic, Rochester, MN; 2Nephrology, Mayo Clinic Health System, Eau Claire, WI; 3Mental Health, North East London NHS Foundation Trust, Ilford, Essex, United Kingdom

    Introduction: We described the syndrome of rapid onset ESRD (SORO-ESRD), acute yet irreversible renal failure, for the first time in the journal Renal Failure in…
  • 2017 American Transplant Congress

    Hurdles to Broader Implementation of the A2/A2BàB Deceased Donor Kidney Allocation Provision.

    I. Kim,1 A. Wilk,2 A. Robinson,2 P. Martins,3 V. Whitaker,4 E. Ward,2 C. Miles.5

    1Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA; 2United Network for Organ Sharing, Richmond, VA; 3Department of Surgery, University of Massachusetts, Worcester, MA; 4Department of Surgery, State University of New York, Syracuse, NY; 5Department of Medicine, University of Nebraska Medical Center, Omaha, NE

    Background: A2/A2B to blood group B kidney transplantation has improved transplant rates among disadvantaged blood group B patients with equivalent long-term graft outcomes. 18 months…
  • 2017 American Transplant Congress

    Manning the Gap: Using Technology to Reduce Barriers in Access to Renal Transplantation Waiting List Across Dialysis Facilities.

    G. Ferreira,1 K. Bastos,2 E. Barbeta,2 B. Pereira,2 G. Souza,1 M. de Souza,1 V. Colares.1

    1Kideny Transplant UPI, Santa Casa de Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil; 2Nephrology, CTDR, Juiz de Fora, Minas Gerais, Brazil

    Background:Pervasive disparities in access to kidney transplantation persist despite decades of recognition and efforts to improve equity in transplant access. Using technology to reduce the…
  • 2017 American Transplant Congress

    Long-Term Outcome of Antibody-Mediated Rejection Due to Pre-Existing vs. De Novo DSA in Kidney Allograft Recipients.

    O. Aubert,1 C. Lefaucheur,1 S. Higgins,1 L. Hidalgo,2 J. Duong Van Huyen,1 D. Viglietti,1 X. Jouven,1 D. Glotz,1 P. Halloran,2 A. Loupy.1

    1Paris Translational Research Center for Organ Transplantation, Paris, France; 2ATAGC, Edmonton, Canada

    BackgroundAntibody-mediated rejection (ABMR) can occur in patients with pre-existing anti-HLA donor-specific antibodies (DSA) or in patients who develop de novo DSA. However, how these processes…
  • 2017 American Transplant Congress

    Prospective Randomized Trial for Predicting CMV Infection According to Baseline CMV-Specific T-Cell Immunity in Kidney Transplant Patients.

    M. Jarque,2 E. Melilli,1 A. Gutierez,3 F. Moreso,4 L. Guirado,5 A. Manonelles,1 J. Cruzado,1,2 S. Luque,2 E. Crespo,2 N. Montero,1 F. Diekman,6 J. Grinyó,1,2 O. Bestard.1

    1Nephrology Dep, Bellvitge Hospital, Barcelona, Spain; 2Nephrology Laboratory, IDIBELL, Barcelona, Spain; 3Kidney Transplant Unit, Hospital Miguel Servet, Zaragoza, Spain; 4Kidney Transplant Unit, Hospital Vall d'Hebrón, Barcelona, Spain; 5Kidney Transplant Unit, Fundació Puigvert, Barcelona, Spain; 6Kidney Transplant Unit, Hospital Clínic, Barcelona, Spain

    Background: Despite the use of either anti-viral prophylaxis (PF) or preemptive (PE) therapy given based on donor/recipient IgG-serostatus, Cytomegalovirus (CMV) reactivation persists after kidney transplantation…
  • 2017 American Transplant Congress

    A Novel 3-Dimensional Culture System Enables In Vitro Study of Human Bone Marrow Plasma Cells.

    J. Driscoll,1 S. Tremblay,2 S. Knechtle,3 E. Woodle.2

    1Medicine, Univ Cincinnati, Cincinnati, OH; 2Surgery, Univ Cincinnati, Cincinnati, OH; 3Transplant, Duke Univ, Durham, NC

    Purpose: Historically, in vitro study of human plasma cells (PCs) has been greatly limited by their short survival (48-72 hrs). Therefore, systems that maintain viability…
  • 2017 American Transplant Congress

    Current Practice and Ethical Dimensions of Implementing APOL1 Testing into Living Donor Evaluation: A National Survey.

    E. Gordon,1 C. Wicklund,1 R. Sharp,2 J. Lee,1 C. Johnson,1 J. Friedewald.1

    1Northwestern University, Chicago; 2Mayo Clinic, Rochester

    BackgroundAfrican American (AA) live kidney donors (LKDs) have an even greater risk of kidney failure than European American live donors. Apolipoprotein 1 (APOL1) gene variants…
  • 2017 American Transplant Congress

    Disease Progression on Neoadjuvant Chemotherapy Is a Strong Predictor of Recurrence for Pediatric Hepatoblastoma.

    M. Kueht,1 S. Commander,1 T.-A. Ha,1 A. Rana,1,2 Y. Shi,1 S. Vasudevan,1,2 J. Goss.1,2

    1Surgery, Baylor College of Medicine, Houston; 2Surgery, Texas Children's Hospital, Houston

    Purpose. In addition to peri-operative chemotherapy, proper triage between orthotopic liver transplantation (OLT) and partial hepatectomy (PH) is critical to limiting disease recurrence in pediatric…
  • 2017 American Transplant Congress

    Antidepressant Medication Use Before and After Kidney Transplant: Implications for Post-Transplant Outcomes.

    K. Lentine,1 A. Naik,2 R. Ouseph,1 Z. Zhang,1 D. Axelrod,3 D. Segev,4 V. Dharnidharka,5 D. Brennan,5 H. Randall,1 R. Gadi,1 N. Lam,6 G. Hess,7 M. Schnitzler,1,8 B. Kasiske.8

    1St. Louis Univ, St. Louis; 2U of Michigan, Ann Arbor; 3East Carolina Univ, Greenville; 4Johns Hopkins, Baltimore; 5Washington Univ, St. Louis; 6Univ Alberta, Edmonton, Canada; 7Symphony Health, Philadelphia; 8Scientific Registry of Transplant Recipients, Minneapolis

    Limited data are available on the implications of antidepressant medication use in kidney transplant recipients.We examined a novel database wherein national transplant registry identifiers for…
  • « Previous Page
  • 1
  • …
  • 134
  • 135
  • 136
  • 137
  • 138
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences